Hib (Haemophilus Influenzae Type B) Vaccine 0.5 mL Suppliers & Bulk Manufacturers
Available Forms: Injectable suspension (IM injection)
Available Strengths: 0.5 mL
Reference Brands: PedvaxHIB,ActHIB(US)
Category: Vaccines
Hib vaccine stimulates the immune system to produce antibodies against Haemophilus influenzae type b bacteria. It prevents invasive diseases like meningitis, pneumonia, and sepsis, reducing morbidity and mortality. Benefits include long-lasting immunity, disease reduction, and protection of vulnerable infants and children from serious bacterial infections.
Product Description:
Hib (Haemophilus influenzae type b) vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and high manufacturing standards aligned with GMP standards. In the US, FDA oversight requires clinical evaluation and safety profiles, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and comprehensive audits, with detailed documentation including safety data, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe and effective Hib vaccines, critical for preventing invasive bacterial diseases worldwide.
Hib (Haemophilus Influenzae Type B) Vaccine — third party manufacturing & bulk supply
Hib (Haemophilus Influenzae Type B) Vaccine 0.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Hib (Haemophilus Influenzae Type B) Vaccine is supplied as Injectable suspension (IM injection) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Hib (Haemophilus Influenzae Type B) Vaccine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Hib (Haemophilus Influenzae Type B) Vacc... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Respiratory Syncytial Virus Mrna Vaccine
Strength:
0.5 mL
Form: injection (prefilled syringe)
Reference Brands: mRESVIA (USA/EU)
View Details
Inactivated Vaccines
Strength:
Dose and concentration depend on formulations
Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution
Reference Brands: Sinovac Coronavac. Covaxin(EU)
View Details
Viral Vector Vaccines
Strength:
0.5 mL
Form: Intramuscular injectable suspension (IM)
Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)
View Details
Mrna-Based Vaccines
Strength:
30 µg and 100 µg
Form: Injectable suspension
Reference Brands: Comirnaty, Spikevax(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
